{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:34:49Z","timestamp":1791862489638,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"European Research Council","award":["291339"],"award-info":[{"award-number":["291339"]}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["104003008"],"award-info":[{"award-number":["104003008"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.apmr.2019.01.016","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T16:38:04Z","timestamp":1550767084000},"page":"1703-1725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"100","author":[{"given":"Aukje","family":"Andringa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"van de Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-9995","authenticated-orcid":false,"given":"Erwin","family":"van Wegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Ket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"Meskers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Kwakkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2019.01.016_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/0269215515593391","article-title":"Common goal areas in the treatment of upper limb spasticity: a multicentre analysis","volume":"30","author":"Ashford","year":"2016","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1191\/026921599677595404","article-title":"A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity","volume":"13","author":"Pandyan","year":"1999","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.2009.177071","article-title":"Stop using the Ashworth Scale for the assessment of spasticity","volume":"81","author":"Fleuren","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2019.01.016_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.apmr.2012.12.006","article-title":"Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis","volume":"94","author":"Foley","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(15)00222-7","article-title":"Botulinum toxin A for upper limb spasticity","volume":"14","author":"Kwakkel","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apmr.2019.01.016_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S0004-282X2005000100006","article-title":"Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis","volume":"63","author":"Cardoso","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.apmr.2019.01.016_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.47102\/annals-acadmedsg.V36N1p22","article-title":"Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice","volume":"36","author":"Francisco","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.apmr.2019.01.016_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00702-007-0869-3","article-title":"Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity","volume":"115","author":"Rosales","year":"2008","journal-title":"J Neural Transm"},{"key":"10.1016\/j.apmr.2019.01.016_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.22452","article-title":"Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review","volume":"24","author":"Elia","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.apmr.2019.01.016_bib11","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.clinthera.2011.01.005","article-title":"Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review","volume":"32","author":"Olvey","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.apmr.2019.01.016_bib12","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0269215513491274","article-title":"The efficacy of botulinum toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach","volume":"27","author":"Baker","year":"2013","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2012.11.025","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","volume":"67","author":"Esquenazi","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.apmr.2019.01.016_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PHM.0000000000000208","article-title":"Systematic literature review of abobotulinumtoxinA in clinical trials for adult upper limb spasticity","volume":"94","author":"Dashtipour","year":"2015","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.23736\/S1973-9087.16.04329-X","article-title":"Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis","volume":"53","author":"Dong","year":"2017","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib16","first-page":"CD008271","article-title":"Botulinum toxin for shoulder pain","volume":"9","author":"Singh","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apmr.2019.01.016_bib17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/0269215514555036","article-title":"The efficacy of botulinum toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach","volume":"29","author":"Baker","year":"2015","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0269215515593609","article-title":"The efficacy of botulinum toxin A for limb spasticity on improving activity restriction and quality of life: a systematic review and meta-analysis using the GRADE approach","volume":"30","author":"Baker","year":"2016","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib19","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2019.01.016_bib20","author":"Higgins"},{"key":"10.1016\/j.apmr.2019.01.016_bib21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0269215508101747","article-title":"Spasticity, an impairment that is poorly defined and poorly measured","volume":"23","author":"Malhotra","year":"2009","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","article-title":"Safety and efficacy of abobotulinumtoxina for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial","volume":"14","author":"Gracies","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apmr.2019.01.016_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1054\/math.2000.0372","article-title":"PEDro. A database of randomized trials and systematic reviews in physiotherapy","volume":"5","author":"Sherrington","year":"2000","journal-title":"Man Ther"},{"key":"10.1016\/j.apmr.2019.01.016_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ptj\/83.8.713","article-title":"Reliability of the PEDro scale for rating quality of randomized controlled trials","volume":"83","author":"Maher","year":"2003","journal-title":"Phys Ther"},{"key":"10.1016\/j.apmr.2019.01.016_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0004-9514(09)70043-1","article-title":"The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study","volume":"55","author":"De Morton","year":"2009","journal-title":"Aust J Physiother"},{"key":"10.1016\/j.apmr.2019.01.016_bib26","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.apmr.2019.01.016_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.apmr.2019.01.016_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/1082-989X.6.3.203","article-title":"The power of statistical tests in meta-analysis","volume":"6","author":"Hedges","year":"2001","journal-title":"Psychol Methods"},{"key":"10.1016\/j.apmr.2019.01.016_bib29","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.apmr.2019.01.016_bib30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2019.01.016_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1191\/026921598668275996","article-title":"Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Hesse","year":"1998","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib32","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2019.01.016_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","article-title":"Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial","volume":"69","author":"Bhakta","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2019.01.016_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/026921500666642221","article-title":"A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury","volume":"14","author":"Smith","year":"2000","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.apmr.2019.01.016_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.apmr.2003.08.077","article-title":"Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial","volume":"85","author":"Brashear","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib38","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke","volume":"85","author":"Childers","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09638280400009360","article-title":"The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity","volume":"27","author":"Suputtitada","year":"2005","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib40","first-page":"859","article-title":"Botulinum toxin type A plus rehabilitative training for improving the motor function of the upper limbs and activities of daily life in patients with stroke and brain injury","volume":"1","author":"Guo","year":"2006","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.apmr.2019.01.016_bib41","first-page":"319","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke","volume":"62","author":"Jahangir","year":"2007","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.apmr.2019.01.016_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269215506072082","article-title":"A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity","volume":"21","author":"Kong","year":"2007","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2340\/16501977-0066","article-title":"Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial","volume":"39","author":"Marco","year":"2007","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib44","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/jnnp.2006.103341","article-title":"Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A","volume":"78","author":"Yelnik","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2019.01.016_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2340\/16501977-0120","article-title":"Associated reactions after stroke: a randomized controlled trial of the effect of botulinum toxin type A","volume":"40","author":"Bhakta","year":"2008","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.2007.128371","article-title":"Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle","volume":"79","author":"De Boer","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2019.01.016_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/STROKEAHA.107.484048","article-title":"Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide","volume":"39","author":"Lim","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2019.01.016_bib48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNF.0b013e3181b13308","article-title":"Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity","volume":"32","author":"Kanovsky","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.apmr.2019.01.016_bib49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2340\/16501977-0366","article-title":"Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes","volume":"41","author":"McCrory","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib50","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.apmr.2009.02.026","article-title":"A preliminary assessment of the benefits of the addition of botulinum toxin A to a conventional therapy program on the function of people with longstanding stroke","volume":"90","author":"Meythaler","year":"2009","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/jnnp.2008.159657","article-title":"Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study","volume":"80","author":"Simpson","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2019.01.016_bib52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269215509358945","article-title":"Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size","volume":"24","author":"Cousins","year":"2010","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib53","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1185\/03007995.2010.497103","article-title":"Botulinum toxin type A in post-stroke upper limb spasticity","volume":"26","author":"Kaji","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.apmr.2019.01.016_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","article-title":"BoTULS: a multicentre randomized controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"14","author":"Shaw","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.apmr.2019.01.016_bib55","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/STROKEAHA.110.582197","article-title":"Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain","volume":"42","author":"Shaw","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2019.01.016_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2340\/16501977-0474","article-title":"Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial","volume":"42","author":"Turner-Stokes","year":"2010","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0269215511421355","article-title":"An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial","volume":"26","author":"Hesse","year":"2012","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib58","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PHM.0b013e31826ecb02","article-title":"Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial","volume":"91","author":"Marciniak","year":"2012","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1545968311430824","article-title":"Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial","volume":"26","author":"Rosales","year":"2012","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.apmr.2019.01.016_bib60","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.apmr.2011.10.026","article-title":"Further assessment to determine the additive effect of botulinum toxin type A on an upper extremity exercise program to enhance function among individuals with chronic stroke but extensor capability","volume":"93","author":"Wolf","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib61","first-page":"47","article-title":"Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity","volume":"12","author":"Yazdchi","year":"2013","journal-title":"Iran J Neurol"},{"key":"10.1016\/j.apmr.2019.01.016_bib62","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.apmr.2014.03.016","article-title":"Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study","volume":"95","author":"Gracies","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib63","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2340\/16501977-1817","article-title":"Functional goal achievement in post-stroke spasticity patients: the BOTOX\u00ae Economic Spasticity Trial (BEST)","volume":"46","author":"Ward","year":"2014","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib64","first-page":"381","article-title":"How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study","volume":"51","author":"Pennati","year":"2015","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/mus.24776","article-title":"Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity","volume":"53","author":"Elovic","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.apmr.2019.01.016_bib66","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.pmrj.2017.06.007","article-title":"Efficacy and safety of abobotulinumtoxina (Dysport) for the treatment of hemiparesis in adults with upper limb spasticity previously treated with botulinum toxin: subanalysis from a phase 3 randomized controlled trial","volume":"9","author":"Marciniak","year":"2017","journal-title":"PM R"},{"key":"10.1016\/j.apmr.2019.01.016_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pmrj.2017.06.008","article-title":"Dose-dependent effects of abobotulinumtoxina (Dysport) on spasticity and active movements in adults with upper limb spasticity: secondary analysis of a phase 3 study","volume":"10","author":"O'Dell","year":"2018","journal-title":"PM R"},{"key":"10.1016\/j.apmr.2019.01.016_bib68","first-page":"526","article-title":"Effect of botulinum toxin A & task-specific training on upper limb function in post-stroke focal dystonia","volume":"68","author":"Umar","year":"2018","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.apmr.2019.01.016_bib69","first-page":"231","article-title":"The interrater and intrarater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect","volume":"23","author":"Ansari","year":"2008","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.apmr.2019.01.016_bib70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.20284","article-title":"Pathophysiology of spastic paresis. I: Paresis and soft tissue changes","volume":"31","author":"Gracies","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.apmr.2019.01.016_bib71","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1474-4422(07)70193-X","article-title":"Spastic movement disorder: impaired reflex function and altered muscle mechanics","volume":"6","author":"Dietz","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.apmr.2019.01.016_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1743-0003-6-29","article-title":"Muscle weakness and lack of reflex gain adaptation predominate during post-stroke posture control of the wrist","volume":"6","author":"Meskers","year":"2009","journal-title":"J Neuroeng Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1743-0003-9-61","article-title":"The gap between clinical gaze and systematic assessment of movement disorders after stroke","volume":"9","author":"Van der Krogt","year":"2012","journal-title":"J Neuroeng Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib74","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/0269215507079141","article-title":"A systematic review of upper extremity casting for children and adults with central nervous system motor disorders","volume":"21","author":"Lannin","year":"2007","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib75","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2340\/16501977-1012","article-title":"Improving walking capacity by surgical correction of equinovarus foot deformity in adult patients with stroke or traumatic brain injury: a systematic review","volume":"44","author":"Renzenbrink","year":"2012","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2019.01.016_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-0003-7-35","article-title":"The relation between neuromechanical parameters and Ashworth score in stroke patients","volume":"7","author":"De Vlugt","year":"2010","journal-title":"J Neuroeng Rehabil"},{"key":"10.1016\/j.apmr.2019.01.016_bib77","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1545968311403494","article-title":"Validation of a new biomechanical model to measure muscle tone in spastic muscles","volume":"25","author":"Lindberg","year":"2011","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.apmr.2019.01.016_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clinbiomech.2016.03.012","article-title":"Estimation of tissue stiffness, reflex activity, optimal muscle length and slack length in stroke patients using an electromyography driven antagonistic wrist model","volume":"35","author":"De Gooijer-van de Groep","year":"2016","journal-title":"Clin Biomech (Bristol, Avon)"},{"key":"10.1016\/j.apmr.2019.01.016_bib79","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.0000105386.05173.5E","article-title":"Spasticity after stroke: its occurrence and association with motor impairments and activity limitations","volume":"35","author":"Sommerfeld","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2019.01.016_bib80","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2016.10.005","article-title":"Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: a meta-analysis","volume":"371","author":"Rosales","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.apmr.2019.01.016_bib81","first-page":"CD009689","article-title":"Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity","volume":"6","author":"Demetrios","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apmr.2019.01.016_bib82","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/1747493018765228","article-title":"Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: protocol for the InTENSE trial","volume":"13","author":"Lannin","year":"2018","journal-title":"Int J Stroke"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999319301078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999319301078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T07:02:20Z","timestamp":1757746940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999319301078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0003999319301078"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2019.01.016","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2019.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Congress of Rehabilitation Medicine","name":"copyright","label":"Copyright"}]}}